Bismuth Subsalicylate Prices Q2 2026: Regional Trends and Market Outlook

According to ChemAnalyst, The Bismuth Subsalicylate Prices remained stable to moderately firm during the second quarter of 2026, with regional price movements reflecting differences in raw material availability, pharmaceutical demand, import dependency, and production economics. Bismuth subsalicylate is an important pharmaceutical compound widely used in over-the-counter gastrointestinal medicines, antidiarrheal formulations, and other healthcare products. Consequently, its pricing is closely linked to pharmaceutical consumption as well as developments in the upstream bismuth market.

During Q2 2026, the North American market recorded prices of approximately USD 35,680/MT on a CFR basis. The market remained relatively stable, although underlying costs showed a firming tendency because North America has limited domestic primary bismuth production and relies substantially on imported bismuth-containing materials and compounds.

In APAC, China experienced a considerably stronger price movement. The Bismuth Subsalicylate Price Index increased by 11.98% quarter-over-quarter, while the average quarterly price was approximately USD 35,236.67/MT, based on exporter assessments. Tighter availability of upstream bismuth supported the increase.

Europe also witnessed a firm pricing environment during the quarter. Stable pharmaceutical demand, imported raw material dependence, and higher upstream bismuth costs contributed to the overall firmness of the market.

Bismuth Subsalicylate Prices in North America

The North American Bismuth Subsalicylate Prices remained comparatively stable during Q2 2026, with prices hovering around USD 35,680/MT CFR. Demand from pharmaceutical manufacturers and producers of over-the-counter gastrointestinal medicines provided a relatively reliable consumption base throughout the quarter.

One of the primary factors supporting prices was North America’s dependence on international supply. Domestic primary bismuth production remains limited, meaning manufacturers and distributors must rely on imported bismuth materials and compounds. This exposes regional buyers to international raw material costs, freight conditions, exchange-rate movements, and supplier availability.

The pharmaceutical sector continued to provide a stable demand foundation. Bismuth subsalicylate is commonly incorporated into formulations designed to address digestive discomfort, diarrhea, heartburn, and related gastrointestinal conditions. Demand for established OTC healthcare products tends to be comparatively resilient, which helped prevent significant downward pressure on prices.

At the same time, buyers remained attentive to upstream bismuth costs. Since bismuth is predominantly recovered as a by-product of the processing of other metals rather than being produced through dedicated primary mining operations, changes in the economics of lead, tungsten, copper, and other associated metal-processing activities can influence availability.

Logistics also remained an important consideration for North American procurement. Imported material carries additional transportation and handling costs, meaning changes in freight rates and supply-chain conditions can quickly influence delivered pricing. As a result, the North American market maintained a stable-to-firm price trend rather than experiencing substantial price declines.

Get Real Time Online for Bismuth Subsalicylate Prices: https://www.chemanalyst.com/Pricing-data/bismuth-subsalicylate-2517

Bismuth Subsalicylate Prices in APAC

The APAC market recorded the strongest price movement among the major regions during Q2 2026. In China, the Bismuth Subsalicylate Price Index rose by 11.98% quarter-over-quarter, while the average price reached approximately USD 35,236.67/MT according to exporter assessments.

The primary factor behind this increase was tighter availability of bismuth feedstock. China plays a significant role in the global bismuth supply chain, and changes in domestic bismuth availability can have an immediate influence on downstream bismuth compounds.

Reduced availability of upstream material placed upward pressure on production costs. Manufacturers of bismuth subsalicylate consequently faced higher input costs, particularly where procurement was conducted under tighter supply conditions. Exporters adjusted offers to reflect these cost pressures, resulting in the quarter-over-quarter increase.

Demand from pharmaceutical applications provided additional support. Although bismuth subsalicylate is a niche chemical compared with bulk pharmaceutical ingredients, its established use in gastrointestinal medicines provides a consistent underlying consumption base.

China’s broader position in the global bismuth industry also means that domestic market developments have implications beyond APAC. Export-oriented producers monitor domestic feedstock availability, production economics, and international inquiries when determining offers. When domestic raw material supply becomes tighter, exporters may prioritize higher-value orders or revise export quotations upward.

The Q2 2026 increase therefore reflected a combination of tighter upstream supply, firm pharmaceutical demand, and higher production costs. The magnitude of the increase made China one of the most notable regional markets for Bismuth Subsalicylate Prices during the quarter.

Bismuth Subsalicylate Prices in Europe

The European Bismuth Subsalicylate Prices market remained firm during Q2 2026. Stable pharmaceutical demand combined with higher upstream bismuth raw material costs to support the market.

Europe continues to depend considerably on imported bismuth compounds and raw materials. China remains an important source within the international bismuth supply chain, making European buyers sensitive to developments in Asian availability and export pricing.

The supply structure of bismuth is particularly important for European pricing. Bismuth is mainly obtained as a by-product from the processing of other metals, including lead and tungsten. Therefore, bismuth availability is not determined solely by demand for bismuth products. Instead, production levels of the associated metals, processing activity, inventories, and refinery economics can all affect the amount of bismuth entering the market.

During Q2 2026, higher upstream costs limited the possibility of significant price reductions. Pharmaceutical manufacturers and distributors continued to procure material to meet ongoing requirements, helping maintain a balanced demand environment.

European buyers also remained exposed to international logistics and import costs. Any increase in transportation, insurance, or handling expenses can add to the landed cost of imported bismuth subsalicylate. This contributed to the firm tone of the European market.

Key Factors Influencing Bismuth Subsalicylate Prices in Q2 2026

Upstream Bismuth Availability

The availability of bismuth was one of the most important pricing factors during the quarter. Since bismuth is largely produced as a by-product of other metal-processing activities, supply can respond differently from conventional primary commodities. Tighter availability of feedstock can therefore quickly increase costs for downstream compound manufacturers.

Pharmaceutical Demand

Pharmaceutical and OTC healthcare applications provided stable demand for bismuth subsalicylate. Its established role in gastrointestinal medicines creates a relatively dependable consumption base. This helped support prices even when broader industrial demand conditions were mixed.

Import Dependency

North America and Europe remain dependent on international sources for bismuth materials. Import reliance exposes buyers to changes in overseas quotations, freight costs, exchange rates, and supply-chain disruptions.

Production Costs

Manufacturing costs include bismuth feedstock, salicylic acid-related inputs, energy, labor, processing, packaging, and quality-control expenses. Any increase in raw material or energy costs can raise the final cost of bismuth subsalicylate.

Export Market Conditions

China’s role in global bismuth supply means changes in Chinese production and export availability can influence international pricing. The 11.98% quarter-over-quarter increase in China’s Bismuth Subsalicylate Price Index highlighted the sensitivity of downstream prices to regional supply conditions.

Regional Comparison of Bismuth Subsalicylate Prices

The Q2 2026 market showed different levels of price movement across major regions. North America remained comparatively stable at approximately USD 35,680/MT CFR, supported by consistent pharmaceutical demand and import dependence.

China recorded a stronger upward movement, with its index increasing 11.98% QoQ and the average quarterly price reaching approximately USD 35,236.67/MT. Tighter bismuth supply was the major contributor to the increase.

Europe remained firm rather than experiencing a sharp price escalation. Its market was supported by stable pharmaceutical demand and elevated upstream bismuth costs, while dependence on imports continued to influence procurement strategies.

Overall, regional markets were connected through the global bismuth supply chain, with developments in China having particular relevance for buyers in Europe and North America.

Supply and Demand Outlook

The balance between bismuth availability and pharmaceutical demand will remain a critical factor for the Bismuth Subsalicylate market. On the supply side, the by-product nature of bismuth production creates structural limitations. Producers cannot always increase bismuth output simply because downstream demand rises.

On the demand side, pharmaceutical consumption is expected to remain an important source of market stability. Established OTC formulations provide recurring requirements from pharmaceutical companies, distributors, and healthcare-product manufacturers.

If upstream bismuth availability remains constrained, downstream manufacturers may face higher procurement costs. Conversely, improved availability of bismuth feedstock and adequate inventories could moderate price pressure.

Bismuth Subsalicylate Prices Forecast

Looking ahead, the Bismuth Subsalicylate Prices outlook remains cautiously firm. The market is expected to continue responding primarily to upstream bismuth availability, pharmaceutical demand, production costs, and international trade conditions.

North American and European markets are likely to remain sensitive to import costs because of their dependence on overseas supplies. Any tightening in Asian availability could translate into higher replacement costs for international buyers.

China’s market will remain particularly important. The Q2 2026 increase of 11.98% demonstrated how quickly downstream prices can respond to tighter raw material conditions. If bismuth feedstock availability improves, some of this pressure could ease. However, sustained pharmaceutical demand may limit the extent of any correction.

For buyers, procurement planning and inventory management will remain important. Long-term supply agreements, diversified sourcing, and monitoring of upstream bismuth prices can help manufacturers manage volatility.

Book A Demo for Bismuth Subsalicylate Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Bismuth%20Subsalicylate

Conclusion

The second quarter of 2026 presented a stable-to-firm market for Bismuth Subsalicylate Prices, with regional differences primarily driven by raw material availability and import exposure. North American prices remained around USD 35,680/MT CFR, supported by steady OTC pharmaceutical demand and limited domestic primary bismuth production.

China experienced the most pronounced increase, with the Bismuth Subsalicylate Price Index rising 11.98% QoQ and the average quarterly price reaching approximately USD 35,236.67/MT. Tighter bismuth availability and firm downstream demand were key drivers.

Europe also maintained a firm pricing environment as stable pharmaceutical consumption coincided with elevated upstream bismuth costs and continued dependence on imported materials.

Overall, the market’s outlook will depend heavily on upstream bismuth supply, pharmaceutical demand, production economics, and international trade conditions. Monitoring these indicators will remain essential for manufacturers, distributors, procurement teams, and pharmaceutical companies seeking to manage Bismuth Subsalicylate Prices effectively.

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Email: [email protected]

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_